News

Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025
Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies ...
Original-Research: PSI SE (von First Berlin Equity Research GmbH): Buy
You can download the research here: http://www.more-ir.de/d/32344.pdf E-Mail: [email protected] Archive at www.eqs-news.com ...
Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...
TMC Welcomes U.S. Executive Order to Expedite Permitting and Evaluate Offtake of Critical Minerals from Nodules in the High Seas
TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), an explorer of the world’s largest undeveloped resource of critical metals for building infrastructure, defense technologies, energy ...
CERo Therapeutics Holdings, Inc. to Present Poster on Lead Program, CER-1236, at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ ...
Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 3 [...]
Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB: CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced ...
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that in connection ...
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the following presentations by the Company or its collaborators at the 2025 Annual Meeting of the ...
Deutsche Außenpolitiker hoffen auf neuen US-Kurs im Ukraine-Krieg
BERLIN (dts Nachrichtenagentur) - Nach dem bilateralen Treffen von US-Präsident Donald Trump und dem ukrainischen Präsidenten Wolodymyr Selenskyj am Samstag in Rom haben sich führende deutsche Außenpo ...
Tandem Diabetes Aktie: Schwacher Jahresverlauf
Die Tandem Diabetes Care Aktie zeigt weiterhin Schwäche: Mit einem Minus von über 50 Prozent im Jahresverlauf gehört das Papier zu den schwächsten Titeln im Medizintechnik-Sektor. Am Freitag notierte ...
Westwing Aktie: Warten auf den Q1-Check
Die Westwing-Aktie zeigt sich nach einem schwachen Monat stabil – doch die entscheidende Bewährungsprobe steht erst noch bevor. Am Freitag schloss das Papier bei 7,72 Euro, mit einem leichten Plus von ...